Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PHILIP LUPO and MICHAEL SCHEURER.
PHILIP LUPO
Connection Strength
15.627
MICHAEL SCHEURER
  1. Using primary teeth and archived dried spots for exposomic studies in children: Exploring new paths in the environmental epidemiology of pediatric cancer. Bioessays. 2021 09; 43(9):e2100030.
    View in: PubMed
    Score: 0.741
  2. Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study. Environ Health. 2014 Jun 13; 13(1):52.
    View in: PubMed
    Score: 0.457
  3. Gene-environment interactions and the risk of childhood acute lymphoblastic leukemia: exploring the role of maternal folate genes and folic Acid fortification. Pediatr Hematol Oncol. 2014 Mar; 31(2):160-8.
    View in: PubMed
    Score: 0.435
  4. Maternal variation in EPHX1, a xenobiotic metabolism gene, is associated with childhood medulloblastoma: an exploratory case-parent triad study. Pediatr Hematol Oncol. 2012 Nov; 29(8):679-85.
    View in: PubMed
    Score: 0.405
  5. A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012 Nov; 23(11):1797-803.
    View in: PubMed
    Score: 0.404
  6. An exploratory case-only analysis of gene-hazardous air pollutant interactions and the risk of childhood medulloblastoma. Pediatr Blood Cancer. 2012 Oct; 59(4):605-10.
    View in: PubMed
    Score: 0.390
  7. Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live births. Neuro Oncol. 2025 Sep 08; 27(7):1910-1922.
    View in: PubMed
    Score: 0.249
  8. The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group. HGG Adv. 2025 Jul 10; 6(3):100466.
    View in: PubMed
    Score: 0.245
  9. All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome. Leukemia. 2025 Jun; 39(6):1516-1519.
    View in: PubMed
    Score: 0.242
  10. Environmental health disparities in pediatric cancer: a?report from the Fourth Symposium on Childhood Cancer Health Disparities. Pediatr Hematol Oncol. 2025 Apr; 42(3):186-203.
    View in: PubMed
    Score: 0.241
  11. Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
    View in: PubMed
    Score: 0.239
  12. Incidence and Survival of Children and Adolescents With Wilms Tumor, United States, 2001-2020. Cancer Med. 2025 Feb; 14(3):e70598.
    View in: PubMed
    Score: 0.239
  13. Overview of the etiology of childhood cancer and future directions. Curr Opin Pediatr. 2025 Feb 01; 37(1):59-66.
    View in: PubMed
    Score: 0.236
  14. Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. medRxiv. 2024 Sep 05.
    View in: PubMed
    Score: 0.232
  15. Splenic complications in pediatric sickle cell disease: A retrospective cohort review. Pediatr Blood Cancer. 2024 Oct; 71(10):e31219.
    View in: PubMed
    Score: 0.230
  16. Residential proximity to oil and gas developments and childhood cancer survival. Cancer. 2024 Nov 01; 130(21):3724-3733.
    View in: PubMed
    Score: 0.229
  17. PM2.5, vegetation density, and childhood cancer: a case-control registry-based study from Texas 1995-2011. J Natl Cancer Inst. 2024 Jun 07; 116(6):876-884.
    View in: PubMed
    Score: 0.228
  18. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. JAMA Netw Open. 2024 03 04; 7(3):e244170.
    View in: PubMed
    Score: 0.224
  19. Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30822.
    View in: PubMed
    Score: 0.221
  20. Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15?000 leukemia cases and 46?000 controls from the Childhood Cancer and Leukemia International Consortium. Int J Cancer. 2024 Feb 01; 154(3):434-447.
    View in: PubMed
    Score: 0.217
  21. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors. Neuro Oncol. 2023 09 05; 25(9):1698-1708.
    View in: PubMed
    Score: 0.216
  22. Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37?000 controls. Int J Cancer. 2024 01 01; 154(1):41-52.
    View in: PubMed
    Score: 0.215
  23. Children's Oncology Group's 2023 blueprint for research: Epidemiology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30566.
    View in: PubMed
    Score: 0.214
  24. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group. J Natl Cancer Inst. 2023 06 08; 115(6):733-741.
    View in: PubMed
    Score: 0.213
  25. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy. 2023 03; 43(3):205-214.
    View in: PubMed
    Score: 0.209
  26. Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Cancer. 2023 04 15; 129(8):1276-1286.
    View in: PubMed
    Score: 0.209
  27. A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities. Front Public Health. 2023; 11:1049727.
    View in: PubMed
    Score: 0.209
  28. Trends in Overall Survival among Patients Treated for Sarcoma at a Large Tertiary Cancer Center between 1986 and 2014. Cancers (Basel). 2023 Jan 14; 15(2).
    View in: PubMed
    Score: 0.207
  29. Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2022 12; 63(12):2948-2954.
    View in: PubMed
    Score: 0.200
  30. An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report. Cancer. 2022 07 15; 128(14):2760-2767.
    View in: PubMed
    Score: 0.197
  31. Associations of demographic and perinatal factors with childhood neuroblastoma in Texas, 1995-2011. Cancer Epidemiol. 2022 06; 78:102165.
    View in: PubMed
    Score: 0.197
  32. A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers. Pediatr Hematol Oncol. 2022 Apr; 39(3):193-202.
    View in: PubMed
    Score: 0.190
  33. Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2278-2285.
    View in: PubMed
    Score: 0.190
  34. Residence in a Hispanic Enclave Is Associated with Inferior Overall Survival among Children with Acute Lymphoblastic Leukemia. Int J Environ Res Public Health. 2021 09 02; 18(17).
    View in: PubMed
    Score: 0.188
  35. Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Natl Cancer Inst. 2021 07 01; 113(7):875-883.
    View in: PubMed
    Score: 0.186
  36. Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis. Sci Rep. 2021 05 17; 11(1):10410.
    View in: PubMed
    Score: 0.184
  37. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatr Blood Cancer. 2021 08; 68(8):e29036.
    View in: PubMed
    Score: 0.183
  38. Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse. Support Care Cancer. 2021 May; 29(5):2455-2464.
    View in: PubMed
    Score: 0.176
  39. Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia. J Pain Symptom Manage. 2021 03; 61(3):464-473.
    View in: PubMed
    Score: 0.176
  40. Altered mechanisms of genital development identified through integration of DNA methylation and genomic measures in hypospadias. Sci Rep. 2020 07 29; 10(1):12715.
    View in: PubMed
    Score: 0.175
  41. Association of population mixing and acute lymphocytic leukemia in children and young adults. Cancer Epidemiol. 2020 06; 66:101722.
    View in: PubMed
    Score: 0.172
  42. Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia. EBioMedicine. 2019 Oct; 48:49-57.
    View in: PubMed
    Score: 0.165
  43. Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. JAMA Oncol. 2019 Aug 01; 5(8):1150-1158.
    View in: PubMed
    Score: 0.163
  44. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment. Cancer. 2019 10 15; 125(20):3623-3630.
    View in: PubMed
    Score: 0.162
  45. Maternal Residential Proximity to Major Roadways and the Risk of Childhood Acute Leukemia: A Population-Based Case-Control Study in Texas, 1995-2011. Int J Environ Res Public Health. 2019 06 07; 16(11).
    View in: PubMed
    Score: 0.161
  46. The role of genetic variation in DGKK on moderate and severe hypospadias. Birth Defects Res. 2019 08 01; 111(13):932-937.
    View in: PubMed
    Score: 0.161
  47. Perinatal and familial risk factors for soft tissue sarcomas in childhood through young adulthood: A population-based assessment in 4 million live births. Int J Cancer. 2020 02 01; 146(3):791-802.
    View in: PubMed
    Score: 0.160
  48. DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Genes Chromosomes Cancer. 2019 01; 58(1):52-59.
    View in: PubMed
    Score: 0.156
  49. Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients. Clin Cancer Res. 2018 10 15; 24(20):5012-5017.
    View in: PubMed
    Score: 0.153
  50. Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia. PLoS One. 2018; 13(5):e0197408.
    View in: PubMed
    Score: 0.150
  51. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110.
    View in: PubMed
    Score: 0.150
  52. The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics. Ann Epidemiol. 2018 08; 28(8):521-528.
    View in: PubMed
    Score: 0.149
  53. DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors. Neuro Oncol. 2017 Oct 01; 19(10):1372-1379.
    View in: PubMed
    Score: 0.144
  54. Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.135
  55. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients. Cancer Epidemiol. 2016 10; 44:161-166.
    View in: PubMed
    Score: 0.133
  56. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics. Cancer. 2016 Dec 01; 122(23):3697-3704.
    View in: PubMed
    Score: 0.133
  57. The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 09; 63(9):1557-62.
    View in: PubMed
    Score: 0.131
  58. Maternal residential proximity to major roadways at delivery and childhood central nervous system tumors. Environ Res. 2016 Apr; 146:315-22.
    View in: PubMed
    Score: 0.128
  59. Differences in environmental exposure assignment due to residential mobility among children with a central nervous system tumor: Texas, 1995-2009. J Expo Sci Environ Epidemiol. 2017 01; 27(1):41-46.
    View in: PubMed
    Score: 0.125
  60. Residential Radon Exposure and Incidence of Childhood Lymphoma in Texas, 1995-2011. Int J Environ Res Public Health. 2015 Sep 25; 12(10):12110-26.
    View in: PubMed
    Score: 0.125
  61. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma. Cancer Med. 2015 Nov; 4(11):1679-86.
    View in: PubMed
    Score: 0.125
  62. Evaluating the Role of Birth Weight and Gestational Age on Acute Lymphoblastic Leukemia Risk Among Those of Hispanic Ethnicity. Pediatr Hematol Oncol. 2015; 32(6):382-9.
    View in: PubMed
    Score: 0.124
  63. Traffic-related air pollution and the incidence of childhood central nervous system tumors: Texas, 2001-2009. Pediatr Blood Cancer. 2015 Sep; 62(9):1572-8.
    View in: PubMed
    Score: 0.122
  64. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis. Pediatr Blood Cancer. 2015 Oct; 62(10):1790-8.
    View in: PubMed
    Score: 0.122
  65. Using a Bayesian hierarchical model for identifying single nucleotide polymorphisms associated with childhood acute lymphoblastic leukemia risk in case-parent triads. PLoS One. 2013; 8(12):e84658.
    View in: PubMed
    Score: 0.110
  66. Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Int J Cancer. 2014 Jan 15; 134(2):431-6.
    View in: PubMed
    Score: 0.108
  67. Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2013 May; 37(5):531-5.
    View in: PubMed
    Score: 0.104
  68. An Analysis of Diagnostic Metabolomic Profiles Associated with Hepatotoxicity During Childhood ALL Induction Therapy. Blood Adv. 2025 Aug 19.
    View in: PubMed
    Score: 0.062
  69. Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000-2014: A Case-control Study. Cancer Epidemiol Biomarkers Prev. 2025 Jul 16.
    View in: PubMed
    Score: 0.062
  70. Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. Oncologist. 2025 Jun 04; 30(6).
    View in: PubMed
    Score: 0.061
  71. The impact of Indigenous American-like ancestry on risk of acute lymphoblastic leukemia in Hispanic/Latino children. medRxiv. 2025 Apr 10.
    View in: PubMed
    Score: 0.060
  72. Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 Jan; 45(1):4-11.
    View in: PubMed
    Score: 0.059
  73. Folate Metabolism and Risk of Childhood Acute Lymphoblastic Leukemia: A Genetic Pathway Analysis from the Childhood Cancer and Leukemia International Consortium. Cancer Epidemiol Biomarkers Prev. 2024 Sep 03; 33(9):1248-1252.
    View in: PubMed
    Score: 0.058
  74. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatr Blood Cancer. 2024 Jan; 71(1):e30732.
    View in: PubMed
    Score: 0.055
  75. Identification of USP9X as a leukemia susceptibility gene. Blood Adv. 2023 08 22; 7(16):4563-4575.
    View in: PubMed
    Score: 0.054
  76. Clustering of Pediatric Brain Tumors in Texas, 2000-2017. Toxics. 2023 Apr 08; 11(4).
    View in: PubMed
    Score: 0.053
  77. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis. Cancer Med. 2023 05; 12(9):10222-10229.
    View in: PubMed
    Score: 0.053
  78. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate. Cancer. 2023 04 15; 129(8):1287-1294.
    View in: PubMed
    Score: 0.052
  79. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor. Pediatr Hematol Oncol. 2023 May; 40(4):407-411.
    View in: PubMed
    Score: 0.050
  80. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Lancet Haematol. 2022 Sep; 9(9):e678-e688.
    View in: PubMed
    Score: 0.050
  81. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022 10; 69(10):e29763.
    View in: PubMed
    Score: 0.049
  82. A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment. Haematologica. 2022 05 01; 107(5):1185-1188.
    View in: PubMed
    Score: 0.049
  83. Residence in a Latinx enclave and end-induction minimal residual disease positivity among children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2022 Oct; 39(7):650-657.
    View in: PubMed
    Score: 0.049
  84. Cancer risk among RECQL4 heterozygotes. Cancer Genet. 2022 04; 262-263:107-110.
    View in: PubMed
    Score: 0.049
  85. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia. Sci Rep. 2021 10 04; 11(1):19613.
    View in: PubMed
    Score: 0.047
  86. Neighborhood deprivation index is associated with weight status among long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv. 2021 10; 15(5):767-775.
    View in: PubMed
    Score: 0.045
  87. Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer. 2021 01 15; 127(2):310-318.
    View in: PubMed
    Score: 0.044
  88. Medical radiation exposure and risk of sporadic retinoblastoma. Pediatr Blood Cancer. 2020 11; 67(11):e28633.
    View in: PubMed
    Score: 0.044
  89. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 09; 67(9):e28525.
    View in: PubMed
    Score: 0.043
  90. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2020 06 08; 37(6):867-882.e12.
    View in: PubMed
    Score: 0.043
  91. Utilization of archived neonatal dried blood spots for genome-wide genotyping. PLoS One. 2020; 15(2):e0229352.
    View in: PubMed
    Score: 0.042
  92. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. Blood. 2019 10 10; 134(15):1227-1237.
    View in: PubMed
    Score: 0.041
  93. Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis. PLoS One. 2019; 14(5):e0217932.
    View in: PubMed
    Score: 0.040
  94. Hypospadias risk is increased with maternal residential exposure to hormonally active hazardous air pollutants. Birth Defects Res. 2019 04 15; 111(7):345-352.
    View in: PubMed
    Score: 0.039
  95. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma. Cancer Epidemiol. 2019 04; 59:71-74.
    View in: PubMed
    Score: 0.039
  96. Evaluation of racial disparities in pediatric optic pathway glioma incidence: Results from the Surveillance, Epidemiology, and End Results Program, 2000-2014. Cancer Epidemiol. 2018 06; 54:90-94.
    View in: PubMed
    Score: 0.037
  97. Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014. J Neurooncol. 2018 Aug; 139(1):69-75.
    View in: PubMed
    Score: 0.037
  98. A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood. 2017 11 16; 130(20):2229-2232.
    View in: PubMed
    Score: 0.036
  99. Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility. PLoS One. 2017; 12(8):e0180488.
    View in: PubMed
    Score: 0.036
  100. Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013. PLoS One. 2017; 12(6):e0179006.
    View in: PubMed
    Score: 0.035
  101. Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Pediatr Blood Cancer. 2017 Sep; 64(9).
    View in: PubMed
    Score: 0.034
  102. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016 Nov; 95(46):e5300.
    View in: PubMed
    Score: 0.034
  103. Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment. J Pediatr Hematol Oncol. 2016 08; 38(6):429-36.
    View in: PubMed
    Score: 0.033
  104. Psychometric Analysis of the Three-Factor Eating Questionnaire-R18V2 in Adolescent and Young Adult-Aged Central Nervous System Tumor Survivors. J Adolesc Young Adult Oncol. 2016 09; 5(3):278-85.
    View in: PubMed
    Score: 0.032
  105. Birth Characteristics and Childhood Leukemia Risk: Correlations With Genetic Markers. J Pediatr Hematol Oncol. 2015 Jul; 37(5):e301-7.
    View in: PubMed
    Score: 0.031
  106. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12):2716-36.
    View in: PubMed
    Score: 0.029
  107. Examination of HFE associations with childhood leukemia risk and extension to other iron regulatory genes. Leuk Res. 2014 Sep; 38(9):1055-60.
    View in: PubMed
    Score: 0.029
  108. Genetic markers in a multi-ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 2015 Jan; 56(1):169-74.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.